Old Web
English
Sign In
Acemap
>
authorDetail
>
Matthias Stölzel
Matthias Stölzel
Astellas Pharma
Mirabegron
Medicine
Urology
Overactive bladder
Adverse effect
3
Papers
223
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An Exploratory Study in Healthy Male Subjects of the Mechanism of Mirabegron‐Induced Cardiovascular Effects
2017
The Journal of Clinical Pharmacology
Marcel van Gelderen
Matthias Stölzel
John Meijer
Virginie Kerbusch
Christiane Collins
Cees Korstanje
Show All
Source
Cite
Save
Citations (15)
Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE Study
2017
European urology focus
William Gibson
Scott MacDiarmid
Moses Huang
Emad Siddiqui
Matthias Stölzel
Nurul Choudhury
Marcus J. Drake
Show All
Source
Cite
Save
Citations (19)
A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder
2013
Urology
Sender Herschorn
Jack Barkin
David Castro-Diaz
Jeffrey Frankel
Montserrat Espuña-Pons
Angelo E. Gousse
Matthias Stölzel
Nancy Martin
Adrie Gunther
Philip Van Kerrebroeck
Show All
Source
Cite
Save
Citations (189)
1